CYTEK BIOSCIENCES, INC. Product Warranty Expense
CYTEK BIOSCIENCES, INC. (CTKB) reported Product Warranty Expense of $623.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProductWarrantyExpense · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. product warranty expense for the quarter ending 2026-06-30 was $221.00K, a 61.36% decline year-over-year.
- CYTEK BIOSCIENCES, INC. product warranty expense for the quarter ending 2026-03-31 was $402.00K, a 272.22% increase year-over-year.
- CYTEK BIOSCIENCES, INC. product warranty expense for the quarter ending 2025-12-31 was $413.00K, a 33.23% increase year-over-year.
- CYTEK BIOSCIENCES, INC. product warranty expense for the quarter ending 2025-09-30 was $344.00K, a 49.78% decline year-over-year.
- CYTEK BIOSCIENCES, INC. product warranty expense for fiscal 2024 was $1.96M, a 31.56% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. product warranty expense for fiscal 2023 was $2.86M, a 15.60% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. product warranty expense for fiscal 2022 was $2.48M, a 1.51% decline from fiscal 2021.
- CYTEK BIOSCIENCES, INC. product warranty expense for fiscal 2021 was $2.51M, a 97.72% increase from fiscal 2020.
| Period end | Product Warranty Expense 3 month | Product Warranty Expense 6 month | Product Warranty Expense 6 month as first filed | Product Warranty Expense 9 month | Product Warranty Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $623.00K 10-Q · filed 2026-08-05 | $1.04M derived: sum of 3 quarters · filed 2026-08-05 | $1.38M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $402.00K 10-Q · filed 2026-05-07 | $815.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.16M derived: sum of 3 quarters · filed 2026-08-05 | $1.73M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $413.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-05 | $757.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.33M derived: sum of 3 quarters · filed 2026-08-05 | $1.44M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $916.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.02M 10-Q · filed 2025-11-05 | $1.33M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $572.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $680.00K 10-Q · filed 2025-08-06 | $990.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.68M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $108.00K 10-Q · filed 2025-05-08 | $418.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.10M derived: sum of 3 quarters · filed 2026-02-26 | $1.49M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $995.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.38M derived: sum of 3 quarters · filed 2026-02-26 | $1.96M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.07M derived: sum of 2 quarters · filed 2024-11-07 | $1.65M 10-Q · filed 2024-11-07 | $2.21M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2024-06-30 | $382.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $963.00K 10-Q · filed 2024-08-06 | $1.52M derived: sum of 3 quarters · filed 2025-02-28 | $2.19M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2024-03-31 | $581.00K 10-Q · filed 2024-05-08 | $1.14M derived: sum of 2 quarters · filed 2025-02-28 | $1.81M derived: sum of 3 quarters · filed 2025-02-28 | $2.70M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-12-31 | $559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.23M derived: sum of 2 quarters · filed 2025-02-28 | $2.12M derived: sum of 3 quarters · filed 2025-02-28 | $2.86M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.56M derived: sum of 2 quarters · filed 2023-11-14 | $2.30M 10-Q · filed 2023-11-14 | $3.02M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2023-06-30 | $898.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.64M 10-Q · filed 2023-08-08 | $2.35M derived: sum of 3 quarters · filed 2024-03-13 | $1.64M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2023-03-31 | $738.00K 10-Q · filed 2023-05-09 | $1.46M derived: sum of 2 quarters · filed 2024-03-13 | $738.00K derived: sum of 3 quarters · filed 2024-03-13 | $2.91M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-12-31 | $717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $0.00 derived: sum of 2 quarters · filed 2024-03-13 | $2.17M derived: sum of 3 quarters · filed 2024-03-13 | $2.48M 10-K · filed 2024-03-13 | |
| 2022-09-30 | -$717.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.45M derived: sum of 2 quarters · filed 2023-08-08 | $1.76M 10-Q · filed 2022-11-09 | $2.11M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.48M 10-Q · filed 2023-08-08 | $979.00K 10-Q · filed 2022-08-10 | $2.82M derived: sum of 3 quarters · filed 2023-08-08 | $3.57M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $307.00K 10-Q · filed 2022-05-12 | $656.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.41M derived: sum of 3 quarters · filed 2023-03-01 | ||
| 2021-12-31 | $349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.10M derived: sum of 2 quarters · filed 2023-03-01 | $2.51M 10-K · filed 2023-03-01 | ||
| 2021-09-30 | $749.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.16M 10-Q · filed 2021-11-12 | |||
| 2021-06-30 | $1.42M 10-Q · filed 2021-09-03 | ||||
| 2020-12-31 | $1.27M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |